SupplierRadar

Beijing Gbi Biotechnical Development Co

FDA import alert and refusal historyBeijing, ChinaFEI 3005551980

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on Beijing Gbi Biotechnical Development Co.

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectBeijing Gbi Biotechnical Development C added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

As of October 26, 2026, Beijing Gbi Biotechnical Development Co (Beijing, China) is on the red list of FDA Import Alert 99-08 (Processed human and animal foods: pesticides) for lycium barbarum (goji berry extract), published by FDA on September 16, 2009, and has no FDA import refusals recorded since October 2016.

Data from FDA public records, last checked . Request a correction

Current status

Last import refusal
None since October 2016
Last warning letter
None found
Last inspection
None on record

Every FDA record for Beijing Gbi Biotechnical Development Co

1 record, newest first. Each line links to the FDA page it came from.

2009

  1. Import alert listing
    Listed on Import Alert 99-08red listLycium Barbarum (Goji Berry Extract)
    Source

Questions about Beijing Gbi Biotechnical Development Co

Is Beijing Gbi Biotechnical Development Co on an FDA import alert?
Yes. As of October 26, 2026, Beijing Gbi Biotechnical Development Co is on the red list of FDA Import Alert 99-08, “Processed human and animal foods: pesticides”, for lycium barbarum (goji berry extract); FDA published the listing on September 16, 2009.
Has FDA refused shipments from Beijing Gbi Biotechnical Development Co?
No FDA import refusals for Beijing Gbi Biotechnical Development Co appear in FDA's refusal data since October 2016, as of October 26, 2026.
What is Beijing Gbi Biotechnical Development Co's FEI number?
Beijing Gbi Biotechnical Development Co's FDA Establishment Identifier (FEI) is 3005551980.
Can shipments from Beijing Gbi Biotechnical Development Co still enter the U.S.?
Shipments of lycium barbarum (goji berry extract) from Beijing Gbi Biotechnical Development Co can be detained without physical examination under Import Alert 99-08; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).

Buying from Beijing Gbi Biotechnical Development Co?

Watch it and get the FDA record the day it changes. Free for one supplier.

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on Beijing Gbi Biotechnical Development Co.

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectBeijing Gbi Biotechnical Development C added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.